Cardio Diagnostics Holdings (NASDAQ: CDIO), a company specializing in AI-driven precision cardiovascular medicine, has released a new edition of its “State of Rural Hospitals and Cardiovascular Care” report. The report is designed to assist rural healthcare leaders, policymakers, and community-based organizations in enhancing the quality and outcomes of cardiovascular care in rural areas. According to the company, the updated report examines persistent challenges such as shortages of specialists and physicians, limited broadband access, and the higher risk of cardiovascular disease among rural populations.
The report presents a revised four-part care model focused on upskilling primary care clinicians, advancing care through epigenetic-genetic testing, implementing population-wide health strategies, and integrating remote care options in rural communities. Cardio Diagnostics emphasized that the revised report also addresses the role of technologies, including virtual cardiac care and precision-medicine testing, in strengthening early detection, access, and personalized care.
This update comes at a critical time, as rural communities continue to face significant health disparities compared to urban areas. Cardiovascular disease remains a leading cause of death in the United States, and rural residents often have limited access to specialized care. The report’s emphasis on leveraging technology and precision medicine could help bridge these gaps, potentially reducing mortality rates and improving quality of life for millions of Americans.
For more details, the full press release is available at https://ibn.fm/H28lM.
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that aims to make cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging its proprietary AI-driven Integrated Genetic-Epigenetic Engine, known as the Core Technology, for cardiovascular disease. The company’s goal is to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease.
For the latest news and updates regarding CDIO, visit the company’s newsroom at https://ibn.fm/CDIO.
